Evolocumab Shows Sustained Cardiovascular Benefits in Older Patients With ASCVD: FOURIER Trial Findings Medha Baranwal10 Feb 2025 9:15 AM ISTUSA: A recent study has highlighted the long-term benefits of evolocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in older...
Inclisiran Lowers LDL Cholesterol Across Glycaemic and BMI Strata, suggests study Dr Riya Dave17 Aug 2024 9:30 AM ISTResearchers have found that inclisiran significantly lowers LDL cholesterol across various glycaemic and BMI strata, with consistent efficacy and...
Alirocumab and high-intensity statin combo may significantly regress coronary plaque burden in familial hypercholesterolemia Medha Baranwal10 Feb 2024 10:00 AM ISTSpain: Alirocumab-combined with high-intensity statin therapy-led to a greater coronary plaque burden (PB) regression in patients with familial...
Alirocumab an efficacious lipid-lowering therapy for children with heterozygous familial hypercholesterolemia: JAMA Medha Baranwal9 Feb 2024 10:30 AM ISTUSA: A randomized clinical trial of 153 patients revealed that alirocumab may be an effective adjunct lipid-lowering therapy (LLT) for pediatric...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Study finds similar primary prevention benefits of lowering LDL cholesterol in younger and older statin users Medha Baranwal11 Oct 2023 10:15 AM ISTDenmark: Findings from a recent study published in the Journal of the American College of Cardiology support a relative clinical benefit of LDL...
Moderate-intensity statins and ezetimibe combo okay for very high-risk ASCVD patients: Analysis of RACING trial Dr. Kamal Kant Kohli8 Aug 2023 11:00 AM ISTKorea: A combination of ezetimibe with a moderate-intensity statin could be considered an effective and feasible therapeutic option for patients at...
Bempedoic acid improves cardiovascular outcomes in statin-intolerant patients, CLEAR Outcomes trial dr. Abhimanyu Uppal4 May 2023 11:00 AM ISTBempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of...
Lipid-lowering trials not representative of patients managed in clinical practice Medha Baranwal17 March 2023 10:00 AM ISTSwitzerland: Patients with common diseases, such as heart failure or moderate-to-severe kidney disease or with immunosuppression, are excluded from...
